sodium glutamate and Dyslipidemia
sodium glutamate has been researched along with Dyslipidemia in 10 studies
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kawamata, Y; Kuwahara, T; Nakamura, H; Sakai, R; Smriga, M | 1 |
Han, MM; Li, DS; Ma, L; Ren, GP; Ye, XL; Yu, D; Zhang, TY; Zhang, ZY; Zhao, JZ; Zhu, SL | 1 |
Cancian, CR; de Oliveira, JC; Fisher, SV; Grassiolli, S; Kanunfre, CC; Leite, Nde C; Martins-Pinge, MC; Montes, EG; Souza, KL | 1 |
Chen, W; Li, S; Liu, HY; Long, L; Wang, LL | 1 |
Al-Johi, M; Al-Mohanna, FA; Al-Rabiah, R; Bakheet, R; Collison, KS; Inglis, A; Makhoul, NJ; Maqbool, Z; Milgram, NW; Mondreal, R; Saleh, SM; Shoukri, M; Zaidi, MZ | 1 |
Al-Johi, MA; Al-Mohanna, FA; Al-Rabiah, RK; Bakheet, RH; Collison, KS; Inglis, AL; Makhoul, NJ; Maqbool, ZM; Saleh, SM; Zaidi, MZ | 1 |
Huan, Y; Li, LY; Liu, Q; Liu, SN; Shen, ZF; Sun, SJ | 1 |
Akamine, EH; Carvalho, MH; Filgueira, FP; Fortes, ZB; Hagihara, GN; Lobato, NS; Pariz, JR; Tostes, RC | 1 |
Ademuyiwa, O; Balogun, EA; Olayiwola, IO; Rotimi, OA | 1 |
Chen, YT; Li, PP; Liu, Q; Lu, XP; Ning, ZQ; Shan, S; Shen, ZF; Sun, SJ; Xie, MZ | 1 |
Other Studies
10 other study(ies) available for sodium glutamate and Dyslipidemia
Article | Year |
---|---|
Long-term ingestion of monosodium L-glutamate did not induce obesity, dyslipidemia or insulin resistance: a two-generation study in mice.
Topics: Abdominal Fat; Adiponectin; Animal Nutritional Physiological Phenomena; Animals; Blood Glucose; Body Composition; Body Weight; Cholesterol; Diet; Dose-Response Relationship, Drug; Dyslipidemias; Fatty Liver; Female; Flavoring Agents; Fructose; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Sodium Glutamate | 2013 |
[Therapeutic effect of fibroblast growth factor 21 on NAFLD in MSG-iR mice and its mechanism].
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Dyslipidemias; Energy Metabolism; Fatty Liver; Female; Fibroblast Growth Factors; Insulin Resistance; Lipolysis; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Sodium Glutamate | 2013 |
Splenectomy attenuates obesity and decreases insulin hypersecretion in hypothalamic obese rats.
Topics: Adiposity; Animals; Dyslipidemias; Hypothalamic Diseases; Insulin; Insulin Resistance; Islets of Langerhans; Male; Nitric Oxide; Obesity; Rats; Rats, Wistar; Sodium Glutamate; Splenectomy | 2015 |
Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
Topics: Animals; Animals, Newborn; Blood Glucose; Cholesterol, HDL; Dyslipidemias; Fatty Acids; Gene Expression; Insulin; Insulin Resistance; Leptin; Metabolic Syndrome; Mice; Mice, Obese; Oxidation-Reduction; PPAR delta; Sodium Glutamate; Thiazoles | 2008 |
Dietary trans-fat combined with monosodium glutamate induces dyslipidemia and impairs spatial memory.
Topics: Adiposity; Animals; Body Weight; Cholesterol; Dietary Fats; Dyslipidemias; Eating; Female; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Sex Characteristics; Sodium Glutamate; Trans Fatty Acids | 2010 |
Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
Topics: Animals; Diet; Dyslipidemias; Fatty Liver; Female; Fructose; Gene Expression; Gene Expression Profiling; Hormones; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Pregnancy; Sodium Glutamate; Zea mays | 2010 |
Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage?
Topics: Adenosine Triphosphatases; Animals; Blood Glucose; Dyslipidemias; Fenofibrate; Glucose; Homeostasis; Insulin; Insulin Secretion; Malondialdehyde; Mitochondria; NF-kappa B; Nitric Oxide Synthase Type II; Obesity; Pancreas; Protein Transport; Rats; Rats, Wistar; Sodium Glutamate; Time Factors; Up-Regulation | 2011 |
Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats.
Topics: Acetylcholine; Animals; Blood Pressure; Body Weight; Disease Models, Animal; Dyslipidemias; Epoprostenol; Hyperinsulinism; Hypoglycemic Agents; Indomethacin; Insulin; Insulin Resistance; Male; Mesenteric Arteries; Metformin; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; Obesity; Rats; Rats, Wistar; Reactive Oxygen Species; Sodium Glutamate; Thromboxane A2 | 2012 |
Effects of fibre-enriched diets on tissue lipid profiles of MSG obese rats.
Topics: Animals; Cholesterol; Dietary Fiber; Disease Models, Animal; Dyslipidemias; Hydroxymethylglutaryl CoA Reductases; Kidney; Lipid Metabolism; Liver; Male; Myocardium; Obesity; Organ Size; Phospholipids; Rats; Sodium Glutamate; Triglycerides; Weight Gain | 2012 |
The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Carbazoles; Disease Models, Animal; Dyslipidemias; Gene Expression; Gluconeogenesis; Hypoglycemic Agents; Insulin Resistance; Lipids; Liver; Liver Glycogen; Muscles; Obesity; Pancreas; Pioglitazone; PPAR alpha; PPAR gamma; Propionates; Pyrimidines; Rats; Rats, Wistar; Rosiglitazone; Sodium Glutamate; Thiazolidinediones | 2006 |